Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
504 Leser
Artikel bewerten:
(2)

Firmenich signs Strategic Partnership Agreement with HARMAY in China

Finanznachrichten News

Collaboration brings expanded value to Fine Fragrance category

GENEVA, Jan. 18, 2022 /PRNewswire/ -- Firmenich, the world's largest privately-owned fragrance and taste company, is proud to announce a new strategic partnership with HARMAY, a leading new retail brand in China. Under the agreement, Firmenich and HARMAY will join forces to contribute to the development of the Fine Fragrance category in China, by leveraging their respective capabilities to support the development of new fragrance brands, concepts, experiences and models.

Firmenich logo

"As a world leader in fine fragrance, Firmenich is focused on leading the transformation of this industry and creating trends to future-proof the business," said Ilaria Resta, President, Global Perfumery, Firmenich. "After more than 30 years of successful operations in China, this partnership with HARMAY serves as a significant enhancement to our capabilities in China and fortifies our ambitions as the partner of choice in the Chinese market."

Founded in 2008, HARMAY is China's premier global beauty collection store, a warehouse-based aesthetic new retail brand with a strong Generation Z customer base. The brand has become synonymous with art and culture in China by offering premium beauty, skincare, fragrance and lifestyle products through its online and offline stores. All of its offline stores feature innovative designs and have gained a loyal following for their unique consumer experience.

"China is projected to be the new frontier of the global fine fragrance market, with many local brands emerging and a significant increasing usage among consumers, especially with Gen Z. We are honored to play a key role in propelling this growth with the synergies between HARMAY and Firmenich," added Jason Ju, Co-founder, HARMAY. "We hope this inspires even greater innovations and creations for the industry."

"Thanks to this strategic partnership with HARMAY we are joining forces to incubate brands of tomorrow and leverage our mutual capabilities in consumers insights, digital, creativity and art of perfumery," added Olivier Viejo, Head of Fine Fragrance, Firmenich China. "This will pave the way for more growth in the Fine Fragrance industry both within China and globally."

As part of its China expansion strategy, Firmenich is bringing additional value to customers by creating highly localized customer journeys, first-hand. In 2019, the company became the first global fragrance house to establish a Fine Fragrance Atelier in China and was the first to offer a dedicated business model that provides easy access to all fine fragrance capabilities under one roof, serving all local customers in China and global customers worldwide. The company also opened its new Studio Guangzhou in September 2021, allowing it to deliver a diverse range of benefits to an even wider base of consumers.

About Firmenich

Firmenich is the world's largest privately-owned perfume and taste company, founded in Geneva, Switzerland, in 1895 and has been family-owned for 125 years. Firmenich is a leading business-to-business company operating primarily in the fragrance and taste market, specialized in the research, creation, manufacture and sale of perfumes, flavors and ingredients. Renowned for its world-class research and creativity, as well as its leadership in sustainability, Firmenich offers its customers superior innovation in formulation, a broad and high-quality palette of ingredients, and proprietary technologies including biotechnology, encapsulation, olfactory science and taste modulation. Firmenich had an annual turnover of 4.3 billion Swiss Francs at end June 2021. More information about Firmenich is available at www.firmenich.com.

Logo - https://mma.prnewswire.com/media/798187/Firmenich_Logo.jpg

© 2022 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.